Injection-site irritation may occur within hours or days
It works by promoting the production of brain-derived neurotrophic factor (BDNF), which supports brain health and neuroplasticity
Key interactions, such as reduced cyclosporin absorption leading to Evan's syndrome relapse, and enhanced effects of warfarin's anticoagulation due to decreased vitamin absorption, underline the importance of vigilant monitoring and potentially supplementing vitamins in individuals taking orlistat [39, 42]
All eligible individuals who initiated the program within the study period were included, resulting in a sample reflective of real-world clinical practice
Patient-specific factors that influence choice include: Concurrent diabetes : Patients with type 2 diabetes may have broader access through NHS prescribing pathways BMI and weight loss goals : Higher BMI patients may benefit from agents with greater weight loss efficacy Tolerability : Previous experience with gastrointestinal side effects may guide selection Injection preference : Some patients strongly prefer weekly over daily injections, or oral over injectable formulations Cardiovascular disease : Certain GLP-1 agonists have proven cardiovascular benefits, which may be relevant for high-risk patients Ultimately, the choice should be individualised through shared decision-making between patient and clinician, considering the available evidence, licensed indications, local prescribing policies, and patient preferences